Hikma Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,750	3,433	4,419	3,955	3,418	5,136
Market Cap Growth	-45.61%	-22.33%	11.74%	15.72%	-33.45%	-11.50%
Enterprise Value	3,790	4,407	5,234	4,766	4,383	5,569
Last Close Price	12.49	15.50	19.29	16.78	14.17	19.78
PE Ratio	9.29	11.49	15.41	26.52	21.91	16.52
Forward PE	7.19	8.95	10.90	10.80	9.65	14.20
PS Ratio	1.11	1.38	1.77	1.75	1.64	2.72
PB Ratio	1.42	1.77	2.38	2.28	1.92	2.82
P/TBV Ratio	2.60	3.25	4.79	4.59	4.07	4.46
P/FCF Ratio	15.48	19.33	13.87	11.48	10.51	14.11
P/OCF Ratio	8.49	10.60	9.81	8.29	7.77	10.90
PEG Ratio	1.15	1.24	1.66	1.55	2.10	1.49
EV/Sales Ratio	1.52	1.77	2.10	2.11	2.10	2.95
EV/EBITDA Ratio	6.15	7.24	8.33	7.62	7.88	10.50
EV/EBIT Ratio	8.16	9.49	10.78	9.71	10.61	13.44
EV/FCF Ratio	21.34	24.82	16.42	13.83	13.47	15.30
Debt / Equity Ratio	0.62	0.62	0.56	0.54	0.60	0.34
Debt / EBITDA Ratio	1.93	1.93	1.64	1.46	1.88	1.16
Debt / FCF Ratio	6.71	6.71	3.27	2.71	3.27	1.72
Net Debt / Equity Ratio	0.53	0.53	0.47	0.44	0.46	0.16
Net Debt / EBITDA Ratio	1.69	1.69	1.39	1.21	1.48	0.55
Net Debt / FCF Ratio	5.80	5.80	2.74	2.19	2.53	0.80
Asset Turnover	0.62	0.62	0.64	0.63	0.57	0.60
Inventory Turnover	1.82	1.82	1.82	1.76	1.70	1.73
Quick Ratio	0.89	0.89	0.60	0.82	1.05	1.31
Current Ratio	1.82	1.82	1.14	1.57	1.86	2.06
Return on Equity (ROE)	16.52%	16.52%	15.98%	8.81%	8.28%	18.20%
Return on Assets (ROA)	7.23%	7.23%	7.75%	8.54%	7.04%	8.24%
Return on Invested Capital (ROIC)	12.28%	13.23%	14.69%	13.54%	13.60%	15.48%
Return on Capital Employed (ROCE)	14.80%	14.80%	19.30%	18.70%	14.70%	16.70%
Earnings Yield	10.86%	8.70%	6.49%	3.77%	4.57%	6.05%
FCF Yield	6.46%	5.17%	7.21%	8.71%	9.52%	7.09%
Dividend Yield	5.03%	4.03%	3.31%	3.37%	3.28%	2.02%
Payout Ratio	46.02%	46.02%	48.75%	72.10%	66.49%	28.50%
Buyback Yield / Dilution	0.36%	0.36%	-0.51%	1.13%	3.47%	2.10%
Total Shareholder Return	5.42%	4.39%	2.81%	4.50%	6.75%	4.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.